BioWorld

March 6, 2008

View Archived Issues

No Buyers, So PDL Plans a Smaller, Leaner Future

After failing to attract a buyer, PDL BioPharma Inc. said it ended efforts to actively sell the company or its key assets, and took steps to streamline operations. (BioWorld Today) Read More

Bevirimat Phase IIb Data Help Panacos Locate Responders

Read More

PanGenetics Raises $34M For Antibody Pipeline

Read More

Ception Launches Phase II/III for Pediatric Esophagus Disorder

Read More

Other News To Note

Read More

Clinic Roundup

Read More